Complete Peptide Therapy Catalog in Oklahoma City | Dosing, Benefits & Regenerative Protocols

Advanced Peptide Therapy in Oklahoma City

Venturis Clinic delivers supervised peptide therapy in Oklahoma City, offering personalized protocols designed to support fat loss, tissue recovery, cognitive performance, hormone balance, and healthy aging. Patients throughout OKC seeking peptide injections OKC can access advanced regenerative medicine backed by 25+ years of clinical experience in functional and alternative medicine. Peptides are also commonly found in dietary supplements marketed for health, muscle growth, and skin benefits. FILL OUT THE FORM HERE TO ORDER https://form.jotform.com/260968966708175

Every protocol begins with a comprehensive medical evaluation to ensure therapies align with individual health profiles and goals.

What peptide therapy may support:

• Weight management and metabolic optimization

• Soft tissue recovery and wound healing

• Hormone and endocrine balance

• Cognitive clarity and stress resilience

• Cellular health and longevity

While many peptides are promoted for their purported benefits in areas such as anti-aging, immune support, and performance enhancement, these claims are not always substantiated by clinical research.

Book Your Peptide Consultation in OKC

A free 15-minute phone consultation is available to discuss whether peptide therapy is appropriate for your situation.

Some peptides discussed on this page are investigational compounds with limited long-term human data. All protocols at Venturis Clinic require medical supervision and informed consent.

---

What Are Peptides and Amino Acids? (Patient-Friendly Primer)

A peptide is a short chain of amino acids—typically between two amino acids and fifty—that serves as a signaling molecule within the human body. In biochemistry, peptides are formed when the carboxyl group of one amino acid reacts with the amino group of another through a condensation reaction, resulting in the formation of a peptide bond. Amino acids are linked together by these peptide bonds to form peptide molecules. Unlike proteins, which often contain many amino acids (50+) and form complex three-dimensional structures, peptides maintain simpler conformations suited for receptor binding and rapid cellular communication. Polypeptides are longer chains of amino acids, often forming part of proteins and exhibiting greater structural complexity.

Your body naturally produces biologically active peptides that function as hormones, neurotransmitters, and repair messengers. Different peptides serve various functions in the body; for example, insulin regulates blood sugar, oxytocin is involved in bonding, and GLP-1 influences appetite and metabolism.

Synthetic peptides and bioidentical versions are produced both naturally in the body and synthetically in the lab. They are created through solid phase peptide synthesis in compounding pharmacies and research labs, using amino acid derivatives and specialized reagents to replicate or modulate the body’s own signaling pathways. The final peptide product undergoes purification to ensure clinical-grade quality.

In a clinical setting, peptide therapy may support metabolic health, tissue recovery, sleep quality, mood stability, and cellular longevity—though peptides are not described as curing or treating disease. Some peptides on this page are FDA approved for specific indications (like semaglutide for type 2 diabetes and chronic weight management), while many others remain investigational or off-label.

At Venturis Clinic, peptides integrate with other regenerative options—stem cell therapies, PRP, exosome therapy, ozone infusions, and hyperbaric oxygen—targeting root causes rather than masking symptoms.

How Peptide Therapy Works at Venturis Clinic (Clinical Process Overview)

Peptide therapy at Venturis Clinic is physician-guided and protocol-based, never a generic one-size-fits-all approach. Each patient undergoes a structured evaluation before any therapy begins.

Evaluation Steps:

• Comprehensive intake and medical history review

• Current medication assessment and interaction screening

• Laboratory work: hormones, metabolic markers, inflammatory markers

• Physical examination as clinically indicated

Providers match peptide categories—weight loss, healing, brain health, hormone support—with patient goals such as chronic joint discomfort, stubborn weight, post-injury recovery, low energy, or brain fog.

Dosing Framework:

All dosing follows a structured peptide dosing guide based on published research, clinical experience, patient age, body weight, and coexisting therapies. Protocols may include:

• Subcutaneous injections (most common)

• Oral capsules or enteric-coated tablets

• Intranasal sprays for brain-targeted peptides

• Sublingual formulations

Staff provide hands-on injection training when appropriate. Ongoing monitoring includes follow-up visits, symptom tracking, side-effect screening, and periodic labs to adjust or discontinue therapy when clinically indicated.

Many performance and longevity peptides follow time-limited cycles (8–16 weeks on, 2–4 weeks off) to reduce receptor desensitization risks.

---

Full Peptide Catalog: Weight Loss & Metabolism

These peptides have been studied for supporting metabolic rate, appetite regulation, insulin sensitivity, and body composition. These compounds belong to different peptide families, each with unique mechanisms of action. At Venturis Clinic, peptides for weight loss are combined with nutrition coaching and lifestyle optimization for sustainable results.

Some compounds (semaglutide) carry FDA approval for specific indications, while others (5-Amino-1MQ, Adipotide, BAM15, SLU-PP-332) are considered investigational and used only under strict medical supervision.

Other peptides with metabolic effects, including additional investigational and proprietary formulations, are also under investigation but are not included in this catalog.

5-Amino-1MQ

Overview: A small molecule that may influence nicotinamide N-methyltransferase (NNMT) activity, potentially impacting fat cell metabolism and NAD+ levels.

Potential Benefits:

• May support brown adipose tissue activation

• Emerging research suggests metabolic rate enhancement

• Preclinical data shows fat mass reduction in animal models

Suggested Clinical Dosing Range:

• Typical protocols: 50–150 mg daily

• Dosing is individualized and determined by a qualified medical provider.

Administration: Oral capsule

5-Amino-1MQ (Oral)

Overview: Same mechanism focus with oral delivery optimized for patient compliance.

Potential Benefits:

• Non-injectable option for metabolic support

• Approximately 40% bioavailability with enteric coating

Suggested Clinical Dosing Range:

• 50–150 mg daily based on patient response

• Dosing is individualized and determined by a qualified medical provider.

Administration: Oral

5-Amino-1MQ + NAD+

Overview: Advanced stack targeting cellular energy pathways and fat cell metabolism simultaneously through sirtuin activation.

Potential Benefits:

• Synergistic metabolic pathway modulation

• May amplify energy expenditure

• Supports cellular NAD+ levels

Suggested Clinical Dosing Range:

• 5-Amino-1MQ: 50–100 mg oral + NAD+ 500–1000 mg IV/subQ

• Dosing is individualized and determined by a qualified medical provider.

Administration: Combined oral and injectable protocols

Adipotide

Overview: A peptide studied for targeting blood vessels supplying white adipose tissue.

Potential Benefits:

• Preclinical studies show fat mass reduction

• Targets adipocyte vasculature selectively

Suggested Clinical Dosing Range:

• Highly investigational; human trials halted due to safety concerns

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous (research context only)

⚠️ Limited human safety data. Used cautiously if at all.

AOD-9604

Overview: A C-terminal fragment of human growth hormone (residues 177-191) studied for supporting fat metabolism without significant IGF-1 elevation.

Potential Benefits:

• May stimulate lipolysis via beta-3 adrenergic pathways

• Does not appear to affect blood pressure or glucose significantly

• Phase IIb data suggests modest fat loss with diet/exercise

Suggested Clinical Dosing Range:

• 1–1.8 mg daily subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

BAM15 (Oral)

Overview: A mitochondrial uncoupler under research for increasing energy expenditure without heat shock activation.

Potential Benefits:

• May increase metabolic rate 15–20% in cell studies

• Oral bioavailability being optimized

Suggested Clinical Dosing Range:

• Conservative start: 100–200 mg daily

• Dosing is individualized and determined by a qualified medical provider.

Administration: Oral

⚠️ Investigational. GI irritation possible.

Cagrilintide

Overview: An amylin analog studied for slowing gastric emptying and enhancing satiety via CTR/AMY receptors.

Potential Benefits:

• Phase II data shows enhanced weight loss when combined with GLP-1 agonists

• May support appetite regulation independently

Suggested Clinical Dosing Range:

• Titrated from 0.3 mg, up to 4.5 mg weekly subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

Retatrutide

Overview: A triple agonist targeting GLP-1, GIP, and glucagon receptors—among the most studied multi-agonist peptides for obesity.

Potential Benefits:

• Phase II trials report up to 24.2% weight loss over 48 weeks

• Addresses multiple metabolic pathways simultaneously

Suggested Clinical Dosing Range:

• Titrated to 12 mg weekly subcutaneous in research protocols

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

⚠️ Investigational. Phase III pending. Nausea common initially.

Retatrutide + Cagrilintide

Overview: Advanced combination targeting multiple appetite and energy pathways for potential additive effects.

Potential Benefits:

• Early research suggests complementary mechanisms

• May provide additional weight loss beyond either alone

Suggested Clinical Dosing Range:

• Combined protocols determined by clinical assessment

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injections

Semaglutide

Overview: A GLP-1 receptor agonist with 94% homology to native GLP-1, FDA approved for type 2 diabetes and chronic weight management.

Potential Benefits:

• STEP trials (n=1961) demonstrated approximately 15% body weight reduction over 68 weeks

• Reduces HbA1c 1.5–2% in diabetic patients

• Well-established safety profile

Suggested Clinical Dosing Range:

• Titrated from 0.25 mg to 2.4 mg weekly subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection (weekly)

Semaglutide Oklahoma City protocols at Venturis integrate with lifestyle support for sustained results.

SLU-PP-332 (Oral)

Overview: An ERR agonist with exercise-mimetic properties through mitochondrial biogenesis pathways.

Potential Benefits:

• Mouse studies (2024) show fat reduction at therapeutic doses

• May support metabolic flexibility

Suggested Clinical Dosing Range:

• 50–200 mg oral (Phase I dosing)

• Dosing is individualized and determined by a qualified medical provider.

Administration: Oral

⚠️ Investigational. Human Phase I underway.

---

Full Peptide Catalog: Healing & Recovery

Regenerative peptides at Venturis Clinic support soft tissue recovery, post-surgical healing, GI lining integrity, and immune system modulation—particularly valuable for patients with severe chronic pain or long-term injuries. Many of these compounds are classified as bioactive peptides due to their roles in tissue repair, immune modulation, and anti-inflammatory activity.

Most are not FDA approved for specific indications, but emerging research suggests benefits for tendon, ligament, and gut barrier support under physician supervision. The current status of research indicates that while preclinical and early clinical data on these peptides are promising, further studies are needed to confirm their efficacy and safety in humans.

BPC-157

Overview: A 15-amino acid gastric pentadecapeptide studied for supporting tendon, ligament, and GI tract tissue repair through FAK-paxillin and VEGF pathways.

Potential Benefits:

• Rat studies demonstrate accelerated Achilles tendon healing

• Human case series (n=12) reports 70% pain reduction for knee osteoarthritis

• May support wound healing and blood vessels formation

Suggested Clinical Dosing Range:

• 200–500 mcg daily, near-site subcutaneous injection

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection (localized or systemic)

BPC-157 (Oral)

Overview: Oral formulation targeting GI mucosal support with stability in stomach acid.

Potential Benefits:

• May support gut barrier integrity

• IBD-model studies show ulceration reduction

Suggested Clinical Dosing Range:

• 300 mcg twice daily oral

• Dosing is individualized and determined by a qualified medical provider.

Administration: Oral capsule

BPC-157 + TB-500

Overview: Combined protocol designed to support both systemic and local tissue healing through complementary mechanisms.

Potential Benefits:

• Rodent studies show 40% faster muscle repair with combination

• TB-500 promotes actin remodeling and cell migration

• Synergistic approach for complex musculoskeletal recovery

Suggested Clinical Dosing Range:

• BPC-157: 200–300 mcg + TB-500: 2–5 mg weekly

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injections

BPC-157 + TB-500 + GHK-Cu

Overview: Expanded blend targeting tissue repair, angiogenesis, and collagen synthesis through multiple pathways.

Potential Benefits:

• Preclinical synergy boosts collagen I production by approximately 50%

• GHK-Cu supports skin elasticity and ECM remodeling

• Advanced regenerative option for complex injuries

Suggested Clinical Dosing Range:

• Combined dosing determined by clinical assessment

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injections

TB-500

Overview: A 43-amino acid synthetic fragment of thymosin beta-4 studied for tissue regeneration and inflammation modulation.

Potential Benefits:

• Promotes keratinocyte migration

• Supports actin-sequestering for cellular repair

• Phase II psoriasis trials demonstrate safety

Suggested Clinical Dosing Range:

• 2–10 mg weekly subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

KPV

Overview: A tripeptide fragment of alpha-MSH (residues 11-13) studied for anti-inflammatory effects via NF-kB suppression.

Potential Benefits:

• IBD mouse models show reduced colitis scores

• May support chronic inflammatory skin diseases

• Localized gut-immune modulation

Suggested Clinical Dosing Range:

• 200–500 mcg subcutaneous or oral

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous or oral

KPV (Oral)

Overview: Oral formulation targeting gut-immune interfaces.

Potential Benefits:

• May support intestinal barrier function

• Conservative protocols due to limited human research

Suggested Clinical Dosing Range:

• 200–500 mcg oral daily

• Dosing is individualized and determined by a qualified medical provider.

Administration: Oral

LL-37

Overview: A 37-amino acid human cathelicidin classified among antimicrobial peptides, studied for immune modulation and biofilm disruption.

Potential Benefits:

• Wound models show enhanced re-epithelialization

• May disrupt bacterial biofilms

• Supports innate immune system function

Suggested Clinical Dosing Range:

• Protocol-dependent; conservative dosing

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous or topical

⚠️ Potential immune overstimulation in susceptible individuals (10% flare rate).

---

Full Peptide Catalog: Muscle Growth & Performance

These peptides have been studied for supporting lean muscle mass, strength, recovery, and body composition. They are often used by patients seeking elite performance medicine rather than competitive sports participation—many are banned by the World Anti Doping Agency.

Venturis Clinic does not promote unsupervised performance enhancement. All protocols comply with ethical and medical safety standards.

IGF-1 LR3

Overview: A long-acting insulin-like growth factor analog (83 amino acids) that evades binding proteins for extended activity, potentially supporting muscle hypertrophy via PI3K/Akt pathways.

Potential Benefits:

• May promote muscle growth and hyperplasia

• 20–30 hour half-life allows sustained signaling

• Recovery support post-training

Suggested Clinical Dosing Range:

• 20–100 mcg post-workout subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

⚠️ Glucose monitoring essential (hypoglycemia risk ~15%).

IGF-1 LR3 + MOTS-C

Overview: Combination targeting muscle anabolism and mitochondrial efficiency simultaneously.

Potential Benefits:

• MOTS-C enhances AMPK for mitochondrial biogenesis

• May boost muscle growth and endurance together

• Advanced performance stack

Suggested Clinical Dosing Range:

• Combined protocols after comprehensive screening

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injections

PEG-MGF

Overview: Pegylated mechano-growth factor (IGF-1 Ec splice variant) studied for localized muscle repair via satellite cell activation.

Potential Benefits:

• May support build muscle recovery post-exercise

• PEGylation extends activity

• Site-specific administration

Suggested Clinical Dosing Range:

• 200–400 mcg per site post-exercise

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection (localized)

Follistatin

Overview: A myostatin-binding protein analog that may promote muscle growth by reducing myostatin’s inhibitory effects.

Potential Benefits:

• Mouse studies show significant mass gains

• Blocks myostatin signaling

• Research shows potential for muscle-wasting conditions

Suggested Clinical Dosing Range:

• Investigational; protocol-dependent

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

⚠️ Concerns about disproportionate growth and unknown long-term safety.

Ipamorelin

Overview: A growth hormone secretagogue (GHS) that stimulates GH release with a relatively targeted receptor profile and minimal cortisol/prolactin effects.

Potential Benefits:

• May pulse GH 5–10x baseline

• Supports recovery, sleep quality, body composition

• One of the cleaner GHS options

Suggested Clinical Dosing Range:

• 200–300 mcg nightly subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

Ipamorelin + CJC-1295

Overview: Common combination providing both pulsatile GH release (Ipamorelin) and extended GHRH activity (CJC-1295 with DAC for prolonged half-life).

Potential Benefits:

• Synergistic GH peaks 3–5x greater than single agents

• May support releasing hormone pathways

• Evening or twice-daily protocols

Suggested Clinical Dosing Range:

• 100 mcg each, administered nightly or twice daily

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injections

Ipamorelin + CJC-1295 + IGF-LR3

Overview: High-intensity performance stack reserved for carefully selected individuals with comprehensive monitoring.

Potential Benefits:

• Maximum GH and IGF-1 pathway activation

• Advanced body composition support

• Requires close cardiovascular and metabolic monitoring

Suggested Clinical Dosing Range:

• Determined after thorough risk screening

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injections

Ipamorelin + Sermorelin

Overview: Protocol supporting more physiologic GH patterns using the 29-amino acid GHRH analog sermorelin.

Potential Benefits:

• Shorter half-life than CJC-1295

• May be preferred for patients seeking reversibility

• Supports natural GH rhythm

Suggested Clinical Dosing Range:

• Sermorelin 0.2–0.3 mg nightly + Ipamorelin 200 mcg

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injections

Hexarelin

Overview: A potent GHS with stronger GH-releasing effects than Ipamorelin.

Potential Benefits:

• Robust GH elevation

• May support recovery in selected patients

Suggested Clinical Dosing Range:

• 200 mcg twice daily; time-limited cycles (16 weeks max)

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

⚠️ Cardiovascular and pituitary safety considerations. Desensitization risk with prolonged use.

---

Full Peptide Catalog: Cognitive & Brain Health

These peptides have been studied for supporting focus, memory, mood stability, sleep architecture, and neuroprotection—relevant for patients with brain fog, stress, long COVID symptoms, or aging-related cognitive concerns.

They are not approved treatments for dementia, depression, or neurological disease but may support brain health as part of comprehensive functional medicine.

Semax

Overview: A synthetic analog of ACTH fragments (4-10) used extensively in Eastern European clinical practice for cognitive support.

Potential Benefits:

• May upregulate BDNF 1.5–2x

• Russian trials (n=100) report improved stroke cognition

• Focus and stress resilience support

Suggested Clinical Dosing Range:

• 300–600 mcg intranasal daily

• Dosing is individualized and determined by a qualified medical provider.

Administration: Intranasal spray

Selank

Overview: A tuftsin analog studied for anxiolytic and nootropic effects via GABAergic and enkephalin modulation.

Potential Benefits:

• Anxiety reduction approximately 40% in phobic subjects

• Supports calm focus

• May enhance immune system function

Suggested Clinical Dosing Range:

• 200–400 mcg intranasal daily

• Dosing is individualized and determined by a qualified medical provider.

Administration: Intranasal or sublingual

DSIP

Overview: Delta Sleep-Inducing Peptide studied for normalizing sleep cycles and stress responses.

Potential Benefits:

• May shorten sleep latency by 25 minutes in trials

• Supports delta wave normalization

• Useful for fragmented sleep patterns

Suggested Clinical Dosing Range:

• 100–250 mcg IV or subcutaneous pre-bed

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous or IV

DSIP + Semax + Selank

Overview: Combined “tri-peptide” stack for cognition, mood, and sleep support.

Potential Benefits:

• Addresses multiple brain health domains simultaneously

• Popular for demanding professionals under chronic stress

• Synergistic nootropic and restorative effects

Suggested Clinical Dosing Range:

• Combined protocols per clinical assessment

• Dosing is individualized and determined by a qualified medical provider.

Administration: Intranasal and subcutaneous

Semax + Selank + DSIP Blend

Overview: Pre-formulated tri-peptide blend for Oklahoma City patients seeking high-functioning performance with better sleep and calm focus.

Suggested Clinical Dosing Range:

• Determined by provider based on symptom profile

• Dosing is individualized and determined by a qualified medical provider.

Administration: Combined formulation

Dihexa (Oral)

Overview: A small peptide derivative studied for synaptogenesis—potentially 7x more potent than BDNF in Alzheimer’s disease models.

Potential Benefits:

• May support memory and cognitive function

• Emerging research in neurodegenerative models

Suggested Clinical Dosing Range:

• 10–20 mg oral

• Dosing is individualized and determined by a qualified medical provider.

Administration: Oral

⚠️ Highly investigational. Neurocognitive monitoring required.

Pinealon

Overview: A short peptide (Glu-Asp-Arg) studied in Russian longevity research for neuroprotective and antioxidant effects.

Potential Benefits:

• May support pineal gland function

• Potential anti aging brain support

Suggested Clinical Dosing Range:

• Protocol-dependent

• Dosing is individualized and determined by a qualified medical provider.

Administration: Oral or injectable

ARA-290

Overview: An 11-amino acid EPO-derived peptide studied for small fiber neuropathy and inflammation modulation.

Potential Benefits:

• Phase II trials show 50% pain reduction in small fiber neuropathy

• May support neuroprotection without erythropoietic effects

Suggested Clinical Dosing Range:

• 4 mg twice daily subcutaneous (research protocols)

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

---

Full Peptide Catalog: Hormone & Endocrine Optimization

These peptides may support the body’s own hormone production by acting upstream on hypothalamus and pituitary, rather than replacing hormones directly. Other peptide hormones, such as C-type natriuretic peptide, also play important roles in cardiovascular and renal physiology, though they are not commonly used in clinical peptide therapy protocols. They require comprehensive labs and endocrine workup at Venturis Clinic.

CJC-1295

Overview: A growth hormone-releasing hormone analog supporting pulsatile GH release affecting body composition, sleep, and recovery.

Suggested Clinical Dosing Range:

• 60 mcg/kg weekly, typically nocturnal administration

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

Sermorelin

Overview: A well-studied 29-amino acid GHRH analog stimulating endogenous growth hormone production.

Potential Benefits:

• Oklahoma clinics report 10–15% IGF-1 elevation

• Shorter half-life favors reversibility

• Supports natural GH patterns

Suggested Clinical Dosing Range:

• 0.2–0.3 mg nightly subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

Gonadorelin

Overview: Synthetic GnRH analog stimulating LH and FSH secretion.

Potential Benefits:

• May support testosterone in men

• Fertility and menstrual hormone support in women

Suggested Clinical Dosing Range:

• 10 mcg three times daily

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

Kisspeptin

Overview: Hypothalamic peptide hormone studied for master regulatory role in reproductive hormone release.

Potential Benefits:

• Emerging research in low-testosterone and infertility

• May double testosterone in some trials

Suggested Clinical Dosing Range:

• 1 mcg/kg; investigational protocols

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

---

Full Peptide Catalog: Sexual Health & Performance

These peptides have been studied for supporting libido, arousal, erectile function, and sexual satisfaction for both men and women in Oklahoma City, Edmond, Norman, and surrounding areas. While some peptides show promising effects in laboratory and animal studies, evidence of their efficacy and safety in humans remains limited and requires further research.

They are used after underlying contributors (hormones, vascular health, medications) are assessed.

PT-141

Overview: Bremelanotide, a melanocortin receptor agonist FDA approved for premenopausal female hypoactive sexual desire disorder.

Potential Benefits:

• Centrally-acting (not vascular like PDE5 inhibitors)

• May support desire and arousal in both sexes

• Effects typically begin within 60 minutes

Suggested Clinical Dosing Range:

• 1.75 mg subcutaneous PRN (as needed)

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

Melanotan-II

Overview: Melanocortin analog originally investigated for tanning and libido effects.

Potential Benefits:

• May enhance libido and arousal

• Skin tanning effect

Suggested Clinical Dosing Range:

• 0.25–1 mg subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

⚠️ Nausea in ~40%. Only pharmacy-grade products with medical oversight.

Oxytocin

Overview: A nine amino acids peptide hormone associated with bonding, trust, and sexual satisfaction.

Potential Benefits:

• May support connection and intimacy

• Compounded intranasal or sublingual forms available

Suggested Clinical Dosing Range:

• 20–40 IU intranasal

• Dosing is individualized and determined by a qualified medical provider.

Administration: Intranasal or sublingual

---

Full Peptide Catalog: Longevity & Cellular Health

These peptides and related compounds focus on cellular repair, mitochondrial resilience, and healthy aging—aligning with Venturis Clinic’s regenerative medicine philosophy.

Many are investigational with promising preclinical data but limited long-term safety information.

Epithalon

Overview: A synthetic analog of pineal peptide epithalamin studied in Russian research for telomere support and healthy aging.

Potential Benefits:

• May activate telomerase

• Sleep quality improvement reported

• Pineal gland support

Suggested Clinical Dosing Range:

• Protocol-dependent; typically cycled

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

GHK-Cu

Overview: A copper-binding tripeptide with research supporting collagen synthesis, wound healing, and skin elasticity.

Potential Benefits:

• Collagen peptides production may increase ~50%

• GHK-Cu levels decline 50% after age 60

• Supports skin and connective tissue

Suggested Clinical Dosing Range:

• Topical, injectable, or systemic depending on goals

• Dosing is individualized and determined by a qualified medical provider.

Administration: Various (topical, subcutaneous)

Note: 2023 FDA restrictions on certain injectable cosmetic applications.

GHK-Cu + Epithalon

Overview: Combination targeting extracellular matrix health and potential telomere/aging pathways.

Suggested Clinical Dosing Range:

• Combined protocols per clinical assessment

• Dosing is individualized and determined by a qualified medical provider.

GHK-Cu + Epithalon + MOTS-C

Overview: Broad longevity stack combining skin/tissue support, aging signaling modulation, and mitochondrial peptide activity.

Suggested Clinical Dosing Range:

• Advanced protocol requiring comprehensive monitoring

• Dosing is individualized and determined by a qualified medical provider.

MOTS-C

Overview: A 16-amino acid mitochondrial-derived peptide studied for metabolic flexibility and exercise capacity.

Potential Benefits:

• Enhances AMPK activation

• May support resistance to age-related metabolic decline

• Exercise-mimetic properties

Suggested Clinical Dosing Range:

• Protocol-dependent

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

NAD+

Overview: While not a peptide, NAD+ is a crucial metabolic cofactor required for cellular energy production, DNA repair, and sirtuin activation—closely related to peptide protocols.

Potential Benefits:

• Supports cellular energy metabolism

• May enhance efficacy of other macromolecules and peptides

• Fatigue and longevity support

Suggested Clinical Dosing Range:

• 500–1000 mg IV infusion or subcutaneous

• Dosing is individualized and determined by a qualified medical provider.

Administration: IV infusion or subcutaneous

Fox-04 DRI

Overview: A senolytic research peptide designed to selectively impact senescent cells.

Potential Benefits:

• May support cellular clearing mechanisms

• Highly investigational longevity tool

Suggested Clinical Dosing Range:

• Research-style use only

• Dosing is individualized and determined by a qualified medical provider.

Administration: Subcutaneous injection

⚠️ Highly investigational. Cautious, research-style use.

Quantum

Overview: A clinic-defined advanced longevity blend bundling mitochondrial and cell-protective agents—may include combinations of promoting peptides and bioactive compounds.

Potential Benefits:

• Multi-pathway mitochondrial support

• Customized anti aging protocol

• Building blocks for cellular resilience

Suggested Clinical Dosing Range:

• Determined by comprehensive clinical evaluation

• Dosing is individualized and determined by a qualified medical provider.

Administration: Combined protocol

---

Peptide Dosing Guide Principles (Clinical Framework)

All dosing at Venturis Clinic follows a “start low, go slow” principle tailored to:

• Age and body weight

• Organ function (liver, kidneys)

• Cardiovascular status

• Concurrent medications and supplements

Key Principles:

Principle	Application
Starting dose	25–50% of target for 1–2 weeks
Cycling	8–12 weeks on, 2–4 weeks off for performance/longevity
Monitoring	Fasting glucose, A1C, IGF-1, lipids, liver function
Adjustment	Titration based on response and labs

Generic dosing from online forums is not used. Patients receive written instructions, injection training, and direct clinic contact in Oklahoma City for emerging questions or side effects.

---

Why Choose Venturis Clinic for Peptide Therapy in OKC?

Venturis Clinic is a leading regenerative and functional medicine center in Oklahoma City, serving patients from OKC, Edmond, Norman, and central Oklahoma.

Key Differentiators:

• 25+ years of clinical experience in regenerative medicine

• Physician-guided peptide therapy with comprehensive evaluation

• Advanced regenerative protocols (stem cell, PRP, exosomes, ozone, hyperbaric oxygen)

• Root-cause functional medicine testing

• Individualized peptide stacks—not generic protocols

• Local access eliminates need for medical tourism

• Integration of lifestyle medicine: nutrition research, sleep optimization, movement

Transparent pricing, clear treatment timelines, and realistic expectations—no “miracle” claims.

---

Safety, Side Effects & Regulatory Status

Safety is the first priority at Venturis Clinic. Many compounds on this page are investigational with limited long-term human health data.

Common Potential Side Effects:

• Local injection-site reactions (20–30% incidence): redness, bruising, irritation

• Nausea, headache, dizziness

• Appetite and sleep changes

• Mood shifts

Class-Specific Concerns:

Peptide Class	Considerations
GLP-1 (semaglutide)	GI upset, nausea
GH-related	Blood sugar, fluid balance
Immune-active (LL-37)	Potential flares in autoimmune patients

Screening Contraindications:

• Pregnancy/breastfeeding

• Active malignancy

• Severe heart disease

• Uncontrolled autoimmune disease

• History of certain endocrine tumors

Important Compliance Notes:

• Some peptides are investigational

• Long-term human data are limited

• All peptide therapy at Venturis Clinic requires medical supervision

⚠️ Self-purchasing peptides online or using “research chemical” suppliers carries contamination, mislabeling, and legal risks. Use only physician-supervised, pharmacy-grade sources.

---

Local Access to Peptide Therapy in Oklahoma City, Edmond & Norman

Venturis Clinic is centrally located in Oklahoma City, routinely serving patients from Edmond, Norman, Yukon, Moore, and the broader OKC metro.

Visit Structure:

• In-person evaluation for initial consult and lab work

• Telehealth follow-ups available for eligible Oklahoma residents

• Quick response to side effects with local access

• Integration with in-clinic therapies: IV infusions, ozone therapy, hyperbaric oxygen, chiropractic care

Whether you’re searching for peptide therapy Oklahoma City, peptides for weight loss, or semaglutide Oklahoma City under physician supervision—Venturis Clinic provides comprehensive local care.

---

Schedule Your Personalized Peptide Consultation

If you’re dealing with chronic pain, stubborn weight, fatigue, brain fog, or healthy-aging concerns, peptide therapy may offer a physician-guided path forward.

Your next step is a comprehensive consultation with a Venturis provider to review symptoms, labs, and medical history—and design a personalized peptide and regenerative plan.

Book Your Peptide Therapy Consultation Now

A free 15-minute phone consultation is available to discuss fit and answer initial questions.

There is no obligation to start therapy after the consult. All recommendations are tailored, with risks, benefits, and alternatives clearly explained.

Peptide therapy is one tool among many at Venturis Clinic, designed to support the body’s own healing and optimization processes under careful medical guidance.

Ready to explore peptide therapy? Fill out the form to order your consultation: https://form.jotform.com/260968966708175